We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Increased Breast Cancer Driving Global Digital Breast Tomosynthesis Market

By Medimaging International staff writers
Posted on 31 Dec 2018
Print article
Image: Breast cancer has become one of the most common malignancies in women across the world and accounts for the second-largest number of diagnosed cases (Photo courtesy of Technavio Research).
Image: Breast cancer has become one of the most common malignancies in women across the world and accounts for the second-largest number of diagnosed cases (Photo courtesy of Technavio Research).
The global digital breast tomosynthesis market is expected to grow at a CAGR of around 13% for the period 2019-2023, driven by the increasing incidence of breast cancer, growing popularity of digital breast tomosynthesis and consistent launch of new products.

These are the latest findings of Technavio Research, (London, UK), a global technology research and advisory company.

Breast cancer has become one of the most common malignancies in women across the world and accounts for the second-largest number of diagnosed cases. Additionally, the associated risk factors for breast cancer are also on the rise. Factors such as lack of physical activity, poor dietary habits, tobacco use, alcohol consumption, and high body mass index are contributing to the rise in cancer incidence. Hence, the increasing incidence of breast cancer is boosting the demand for digital breast tomosynthesis and in turn, fueling the growth of the market.

Based on product, the 2D/3D combination systems segment is expected to account for the highest share in the digital breast tomosynthesis market. The use of computer-aided detection (CAD) for digital breast tomosynthesis is one of the major trends being witnessed in the market. CAD systems are playing an increasingly pivotal role in the interpretation of digital breast tomosynthesis images, aiding clinicians in detecting lesions with higher efficiency and effectiveness. CAD has the potential to increase cancer detection rates, reduce the 3D tomosynthesis interpretation time and optimize reading workflow, and reduce false-positive rates. The use of CAD systems is helping to overcome some of the limitations of the existing digital breast tomosynthesis.

Geographically, the Americas held the largest market share of more than 74% in 2018, followed by the EMEA and APAC. The Americas is expected to continue dominating the digital breast tomosynthesis market during the forecast period with the highest incremental growth.

Related Links:
Technavio Research


Print article

Channels

Copyright © 2000-2019 Globetech Media. All rights reserved.